Eli Lilly and Company

Patent Owner

Follow Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology MATTERS Rank in Class
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 501 23
 
 
C07D HETEROCYCLIC COMPOUNDS 316 18
 
 
C07K PEPTIDES 107 40
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 60 37
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 58 86
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 45 112
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 39 96
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 37 64
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 33 24
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 28 67
  • No Technologies to Display

Top Patents (by citation)

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0333,005 ISOPROPYL TRIAZOLO PYRIDINE COMPOUNDS Jan 06, 15 Nov 17, 16 [C07D]
2016/0326,208 5'-SUBSTITUTED NUCLEOSIDE COMPOUNDS Apr 27, 16 Nov 10, 16 [C07H]
2016/0318,953 Selective BACE1 Inhibitors Apr 22, 16 Nov 03, 16 [C07D, C07C]
2016/0272,585 Phenoxyethyl Cyclic Amine Derivatives and Their Activity as EP4 Receptor Modulators Dec 11, 14 Sep 22, 16 [C07D]
2016/0251,306 DIMETHYLBENZOIC ACID COMPOUNDS Dec 11, 14 Sep 01, 16 [C07C]
2016/0251,348 PYRIDO[2,3-d]PYRIMIDIN-4-ONE COMPOUNDS AS TANKYRASE INHIBITORS Oct 29, 14 Sep 01, 16 [C07D]
2016/0251,430 ANTI-BAFF-ANTI-IL-17 BISPECIFIC ANTIBODIES May 18, 16 Sep 01, 16 [C07K]
2016/0244,465 SELECTIVE BACE1 INHIBITORS Feb 17, 16 Aug 25, 16 [C07D, C07C]
2016/0235,823 METHODS AND COMPOSITIONS FOR REDUCING THE ENVIRONMENTAL IMPACT OF ANIMAL WASTE Apr 29, 16 Aug 18, 16 [A23K, A61K]
2016/0229,835 NOVEL PYRIDYLOXYACETYL TETRAHYDROISOQUINOLINE COMPOUNDS USEFUL AS NAMPT INHIBITORS Oct 03, 14 Aug 11, 16 [C07D, A61K]

View all publication…

  • No Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,505,838 Method to treat migraines using CGRP antibodies Jun 04, 15 Nov 29, 16 [A61K, G01N, C07K]
9,499,490 Fluorophenyl pyrazol compounds Dec 11, 14 Nov 22, 16 [C07D, A61K]
9,481,688 antagonists Jul 02, 12 Nov 01, 16 [C07D, A61K]
9,474,780 GIP and GLP-1 co-agonist compounds Jan 05, 16 Oct 25, 16 [A61K, C07K]
D770038 Medication injection device Jun 26, 14 Oct 25, 16 [2402]
9,469,632 -1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonists May 21, 15 Oct 18, 16 [C07D, A61K]
9,469,652 ERK inhibitors Dec 16, 15 Oct 18, 16 [C07D]
9,453,069 Assay method for Alzheimer's disease Apr 16, 13 Sep 27, 16 [A61K, G01N, C07K]
9,453,073 Anti-glucagon antibodies and uses thereof Nov 27, 12 Sep 27, 16 [G01N, A61K, C07K]
9,439,952 Rapid-acting insulin compositions May 04, 15 Sep 13, 16 [A61K]

View all Patent…

  • No Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0376,178 Pyridinoylpiperidines As 5-HT1F Agonists ABAN Jun 05, 14 Dec 31, 15 [C07D]
2015/0203,471 METHODS FOR IMPROVING CHICKEN PRODUCTION ABAN Sep 24, 13 Jul 23, 15 [C07D, C07C, A23K]
2015/0152,158 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Feb 10, 15 Jun 04, 15 [C07K]
2015/0141,335 THERAPEUTIC USES OF FIBROBLAST GROWTH FACTOR 21 PROTEINS ABAN May 09, 13 May 21, 15 [A61K]
2015/0045,313 Ectoparasiticidal Methods and Formulations ABAN Oct 28, 14 Feb 12, 15 [A01N]
2014/0271,671 RANDOM HOMOZYGOUS GENE PERTURBATION (RHGP) WITH THERMAL ASSYMETRIC INTERLACED (TAIL)-PCR ABAN Mar 14, 13 Sep 18, 14 [C12Q]
2014/0275,049 SUBSTITUTED PYRAZOLE ANALOGS As RAR ANTAGONISTS ABAN Oct 19, 12 Sep 18, 14 [C07D, A61K]
2014/0206,613 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Mar 31, 14 Jul 24, 14 [C07K]
2014/0206,877 NOVEL INTERMEDIATE AND PROCESS USEFUL IN THE PREPARATION OF -(2-CHLOROPHENYL)-METHANONE ABAN Mar 27, 14 Jul 24, 14 [C07D]
2014/0171,497 ANIMAL SUPPLEMENTS AND COMPOSITIONS CONTAINING SOLUABLE MONENSIN AND METHODS THEREFOR ABAN Jul 26, 12 Jun 19, 14 [A23K, A61K]
2014/0163,097 ANIMAL SUPPLEMENTS AND FOOD COMPOSITIONS CONTAINING SOLUBLE MONENSIN COMPOSITION, AND METHODS AND PROCESSES THEREFOR ABAN Jul 26, 12 Jun 12, 14 [A23K, A61K]
2014/0056,893 Homodimeric Proteins ABAN Aug 15, 13 Feb 27, 14 [C07K]
2014/0050,763 MODIFIED VIRAL PARTICLES WITH IMMUNOGENIC PROPERTIES AND REDUCED LIPID CONTENT USEFUL FOR TREATING AND PREVENTING INFECTIOUS DISEASES ABAN Oct 30, 13 Feb 20, 14 [A61K]
2014/0024,586 USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY ABAN Oct 03, 13 Jan 23, 14 [A61K]
2013/0228,136 LIQUID DISPENSER ABAN Apr 17, 13 Sep 05, 13 [A01K]
2013/0023,471 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Sep 14, 12 Jan 24, 13 [A61P, A61K]
2012/0323,001 BACE INHIBITORS ABAN Aug 16, 12 Dec 20, 12 [C07D]
2012/0302,547 NOVEL MCH RECEPTOR ANTAGONISTS ABAN Aug 08, 12 Nov 29, 12 [C07D, A61P, A61K]
2012/0294,855 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA ABAN Oct 28, 10 Nov 22, 12 [A61P, A61K]
2012/0231,022 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR SLEEP ENHANCEMENT ABAN May 27, 10 Sep 13, 12 [A61P, A61K]

View all Patent…

  • No Patents to Display

Top Inventors for This Owner

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

Owner Follow
Eli Lilly and Company
CANCEL
UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to comparisons!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of portfolios () for this membership level. Upgrade to our Level for up to portfolios!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of patents allowed in portfolios () for this membership level. Upgrade to our Level for up to patents!

UPGRADE MEMBERSHIP CANCEL